Press Releases

In Vitro Diagnostics Market to Reach US$ 125.5 Bn by 2030

Share This Article

The global In Vitro Diagnostics market size is expected to reach USD 125.5 billion by 2030 and is expected to expand at a CAGR of 5.6% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38659

Growth Factors

 The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

Report Coverage

Report Scope Details
Market Size USD 125.5 billion by 2030
Growth Rate CAGR of 5.6% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Technology, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott, Danaher; bioMérieux SA; Bio-Rad Laboratories, Inc.; Becton; Dickinson and Company; Siemens Healthineers AG; QIAGEN; Quidel Corporation; F. Hoffmann-La Roche AG; Sysmex Corporation; Charles River Laboratories International, Inc.; Quest Diagnostics; Agilent Technologies

By Product Analysis

The reagents segment dominated the market for in vitro diagnostic and led for the largest revenue share of 66.3% in 2020. The growth of this segment can be attributed to the increasing demand for rapid, accurate, and sensitive devices.

Equipment and machines that assist in automating the process of diagnosis and bringing reagents and samples together are referred to as analytical instruments. Commercial kits and robots are used in polymerase chain reaction (PCR) laboratories to help detect and quantify infectious microorganisms, blood antigens, and viral load.

Equipment and machines that assist in automating the process of diagnosis and bringing reagents and samples together are referred to as analytical instruments. Commercial kits and robots are used in polymerase chain reaction (PCR) laboratories to help detect and quantify infectious microorganisms, blood antigens, and viral load.

By Application Analysis

The infectious disease segment dominated the market and led for the largest revenue share of 42.8% in 2020, which is attributable to the increasing incidence of infectious diseases such as SARS-CoV-2, HIV, AIDS, tuberculosis, and pneumonia.

Cancer, a chronic disease, is one of the major causes of death globally. The most common types of cancers are colorectal, prostate, breast, and lung. The increasing prevalence of cancer is expected to accelerate the demand for in vitro diagnostic tests.

Alcohol abuse, smoking, unhealthy diet, decreased physical activity, and high blood pressure are expected to increase the risk for cardiovascular diseases. The introduction of PoC devices for quick and on-site diagnosis, especially in emergency cases, is expected to drive the market.

By End-use Analysis

The hospital segment dominated the market and led for the largest revenue share of 45.2% in 2020. This is owing to an increase in hospitalization as doctors require diagnostic interpretation for further treatment. Most often, diagnostic centers operate in collaboration with hospitals; hence, hospitals have their own diagnostic set up.

Home care refers to supportive care provided at home by licensed healthcare professionals, or self-care by patients. Self-care devices account for the majority share of the home care segment. It is more convenient and reduces hospital visits.

Other end-users of in vitro diagnostics are other healthcare settings, laboratories, ambulatory care services, schools, and academic institutions, especially in emergency cases and research institutes. These healthcare institutions mostly perform POC tests for monitoring or detecting diseases.

By Technology Analysis

 The immunoassay segment led the market and accounted for the largest revenue share of 30.8% in 2020. It is anticipated to grow at a lucrative rate in upcoming years owing to its use in the detection of infectious microbes, such as fungus, bacteria, and viruses, by detection of their toxins.

Clinical chemistry is the practical application of biochemistry and is used to analyze body fluids for diagnostic and therapeutic purposes. Serum, plasma, and urine are the most commonly tested samples in pathology. The increasing use of approved blood-gas analyzers to monitor respiratory conditions is expected to fuel the growth of the market for in vitro diagnostic.

The microbiology segment includes tests and assays for the identification of infectious microorganisms. An increase in initiatives by organizations to improve patient outcomes using cost-effective and rapid diagnostic techniques, to help fight antibiotic resistance, is expected to fuel market growth.

By Regional Analysis

North America dominated for the largest revenue share of 42.1% in the IVD market in 2020 and is expected to continue its dominance over the forecast period. This is attributable to the local presence of major market players.

In Asia Pacific, the market is expected to witness the fastest growth over the forecast period, with a CAGR of 6.2%. Asia Pacific consists of developing and developed economies.

Key Players

  • Abbott
  • Danaher
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN
  • Quidel Corporation
  • F. Hoffmann-La Roche AG
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • Quest Diagnostics
  • Agilent Technologies

Market Segmentation

  • Product
    • Instruments
    • Reagents
    • Services
  • Technology
    • Immunoassay
      • Instruments
      • Reagents
      • Services
    • Hematology
      • Instruments
      • Reagents
      • Services
    • Clinical Chemistry
      • Instruments
      • Reagents
      • Services
    • Molecular Diagnostics
      • Instruments
      • Reagents
      • Services
    • Coagulation
      • Instruments
      • Reagents
      • Services
    • Microbiology
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Application
    • Infectious Disease
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Disease
    • Drug testing
    • Others
  • End-use
    • Hospitals
    • Laboratories
    • Home Care
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Singapore
      • Australia
    • Latin America
      • Brazil
      • Argentina
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38659

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global In Vitro Diagnostics Market, By Product

7.1.  In Vitro Diagnostics Market, by Product, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global In Vitro Diagnostics Market, By Technology

8.1.  In Vitro Diagnostics Market, by Technology, 2021-2030

8.1.1.    Immunoassay

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Hematology

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Clinical Chemistry

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Molecular Diagnostics

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Coagulation

8.1.5.1.        Market Revenue and Forecast (2017-2030)

8.1.6.    Microbiology

8.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global In Vitro Diagnostics Market, By Application

9.1.  In Vitro Diagnostics Market, by Application, 2021-2030

9.1.1.    Infectious Disease

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Diabetes

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Oncology

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Cardiology

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Nephrology

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Autoimmune Disease

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Drug testing

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global In Vitro Diagnostics Market, By End-use

10.1.        In Vitro Diagnostics Market, by End-use, 2021-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Laboratories

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Home Care

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Others

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global In Vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Abbott

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Danaher

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              bioMérieux SA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Bio-Rad Laboratories, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Becton, Dickinson and Company

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Siemens Healthineers AG

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              QIAGEN

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Quidel Corporation

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              F. Hoffmann-La Roche AG

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Sysmex Corporation

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Charles River Laboratories International, Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38659

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button